These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 17127334)

  • 1. The role of tau phosphorylation and cleavage in neuronal cell death.
    Chun W; Johnson GV
    Front Biosci; 2007 Jan; 12():733-56. PubMed ID: 17127334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau and tauopathies.
    Robert M; Mathuranath PS
    Neurol India; 2007; 55(1):11-6. PubMed ID: 17272893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatamopathological spectrum of tauopathies.
    Revesz T; Holton JL
    Mov Disord; 2003 Sep; 18 Suppl 6():S13-20. PubMed ID: 14502651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
    Spillantini MG; Van Swieten JC; Goedert M
    Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tau story: from frontotemporal dementia to other tauopathies].
    Buée L; Hamdane M; Delobel P; Sambo AV; Bégard S; Ghestem A; Sergeant N; Delacourte A
    J Soc Biol; 2002; 196(1):103-8. PubMed ID: 12134624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau protein as a differential biomarker of tauopathies.
    Sergeant N; Delacourte A; Buée L
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):179-97. PubMed ID: 15615637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
    Wang Y; Wang J; Gao L; Stamm S; Andreadis A
    Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontotemporal dementia: tau mutations, deposition, and molecular mechanisms of neuronal cell death].
    Hasegawa M
    Rinsho Shinkeigaku; 2004 Nov; 44(11):879-81. PubMed ID: 15651320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary frontotemporal dementia caused by Tau gene mutations.
    van Swieten J; Spillantini MG
    Brain Pathol; 2007 Jan; 17(1):63-73. PubMed ID: 17493040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau, where are we now?
    Johnson GV; Bailey CD
    J Alzheimers Dis; 2002 Oct; 4(5):375-98. PubMed ID: 12446970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process.
    Goedert M; Ghetti B; Spillantini MG
    Ann N Y Acad Sci; 2000; 920():74-83. PubMed ID: 11193179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals.
    Chen F; David D; Ferrari A; Götz J
    Curr Drug Targets; 2004 Aug; 5(6):503-15. PubMed ID: 15270197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.
    Zhou J; Yu Q; Zou T
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S10. PubMed ID: 19090983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease.
    Shiarli AM; Jennings R; Shi J; Bailey K; Davidson Y; Tian J; Bigio EH; Ghetti B; Murrell JR; Delisle MB; Mirra S; Crain B; Zolo P; Arima K; Iseki E; Murayama S; Kretzschmar H; Neumann M; Lippa C; Halliday G; Mackenzie J; Khan N; Ravid R; Dickson D; Wszolek Z; Iwatsubo T; Pickering-Brown SM; Mann DM
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):374-87. PubMed ID: 16866983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodegenerative tauopathies.
    Lee VM; Goedert M; Trojanowski JQ
    Annu Rev Neurosci; 2001; 24():1121-59. PubMed ID: 11520930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
    García-Escudero V; Ruiz-Gabarre D; Gargini R; Pérez M; García E; Cuadros R; Hernández IH; Cabrera JR; García-Escudero R; Lucas JJ; Hernández F; Ávila J
    Acta Neuropathol; 2021 Jul; 142(1):159-177. PubMed ID: 33934221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.